01/17/2025
7:13 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
7:17 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/16/2025
5:51 AM | Lipella Pharmaceuticals (Filer)
| Form 424B3 | |
01/15/2025
11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
01/13/2025
7:42 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
4:25 PM | Lipella Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/07/2025
4:28 PM | Lipella Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/06/2025
4:25 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
8:22 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
8:25 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
3:11 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/27/2024
8:28 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
8:31 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
12/27/2024
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:29 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:26 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
4:01 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:24 PM | Lipella Pharmaceuticals (Filer)
| Form PRE 14A | |
11/01/2024
4:00 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
4:00 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/17/2024
4:00 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/11/2024
4:10 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:05 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
08/13/2024
3:13 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:44 AM | Lipella Pharmaceuticals (Filer)
| Form ARS | |
08/12/2024
7:25 AM | Lipella Pharmaceuticals (Filer)
| Form DEF 14A | |
08/06/2024
3:50 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
4:20 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
10:50 AM | Lipella Pharmaceuticals (Filer)
| Form 424B5 | |
05/15/2024
3:39 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
5:25 PM | Lipella Pharmaceuticals (Issuer)
Yoshimura Naoki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:26 PM | Lipella Pharmaceuticals (Issuer)
Pruchnic Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:15 PM | Kim Byong (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:18 PM | Cohen Daniel R (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:19 PM | Johnston Douglas (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:21 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:22 PM | Birder Lori (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Stunning Trump Manhattan Project Now Underway (Ad) Just as I predicted, President Trump announced his #1 move during his first 100 days...
His allies are calling it Trump’s Manhattan Project. You simply have to see this.. |
03/19/2024
5:24 PM | Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
12:31 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
11:19 AM | Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:20 AM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:13 AM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/15/2024
11:15 AM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/15/2024
5:04 AM | Lipella Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2024
4:03 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/06/2024
4:05 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
02/08/2024
11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
02/07/2024
4:29 PM | Gruber Michele (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13G/A | |
